Wuqing Wang

Dr. Wuqing Wang


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2025 in Molecular Medicine
Verified
Journal Article
Open access
PDF file
WLWen Li
Wen Li
KZKan Ze
Kan Ze
XHXufeng He
Xufeng He
LYLili Yang
Lili Yang
HZHuimin Zhang
Huimin Zhang
WWWuqing Wang
Wuqing Wang
Background: Psoriasis is a chronic inflammatory skin disorder characterized by hyperproliferative keratinocytes and an altered immune response. PIEZO1 , a mechanically activated ion channel, has been implicated in various cellular processes, but its role in psoriasis pathogenesis remains unclear. Methods: We examined PIEZO1 expression in skin samples from psoriatic patients and healthy individuals using western blot, immunohistochemistry, and mRNA expression analyses. Subsequently, we employed PIEZO1 knock-out (KO) mice to establish imiquimod (IMQ)-induced psoriasiform models for in vivo experiments. Additionally, we conducted in vitro experiments with PIEZO1 -silenced human keratinocytes (HaCaT cells) to investigate the impact on keratinocyte function and the expression of inflammatory cytokines. Results: PIEZO1 expression was significantly upregulated in the basal layer of psoriatic lesions compared to healthy controls. In vivo, PIEZO1 KO mice showed attenuated psoriasis-like symptoms, reduced keratinocyte proliferation, inflammatory cell infiltration, and less Th17 cells compared to wild-type mice. Loss of PIEZO1 in vitro inhibited keratinocyte proliferation and migration, while inducing apoptosis. Transcriptome sequencing and subsequent analyses revealed that PIEZO1 knockdown modulates the NF-kB signaling pathway and associated inflammatory genes. The in vitro activation of NF-kB signaling was diminished by PIEZO1 silencing in keratinocytes, resulting in decreased inflammatory cytokine and chemokine expression. Furthermore, PIEZO1 facilitated keratinocyte-mediated CD4 + T cell differentiation into Th17 cells, a key pathogenic factor in psoriasis. Conclusion: This study highlights the critical role of PIEZO1 in psoriatic skin inflammation and suggests that PIEZO1 may serve as a novel therapeutic target for psoriasis treatment. Our findings reveal that PIEZO1 modulates keratinocyte proliferation, immune cell infiltration, and T cell differentiation through the NF-kB signaling pathway, contributing to the complex pathophysiology of psoriasis.

15 June 2025 in Phytomedicine
Verified
Journal Article
Closed access
HZHuixing Zhang
Huixing Zhang
LSLin Su
Lin Su
YQYan Qiang
Yan Qiang
JCJunnan Chen
Junnan Chen
SHShiyu Hang
Shiyu Hang
CZChunpu Zou
Chunpu Zou

12 March 2026 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
QLQiannan Li
Qiannan Li
LGLanxin Geng
Lanxin Geng
XHXufeng He
Xufeng He
XWXiangyu Wei
Xiangyu Wei
CZCheng Zhang
Cheng Zhang
WWWuqing Wang
Wuqing Wang
Introduction: The clinical manifestations and presentation of rhinophyma closely resemble those of hypertrophic scar tissue, both presenting as firm, fibrotic growths. Despite this phenotypic similarity, a critical divergence is observed following surgical intervention: the affected skin in rhinophyma can revert to its normal state without scar recurrence, a favorable outcome starkly contrasting with the behavior of hypertrophic scars. The underlying mechanisms for this phenomenon have yet to be elucidated. The aim of this study is to uncover the cellular and molecular disparities between these two pathological conditions using single-cell sequencing technology to resolve this clinical paradox. The objective of this study is to compare the single-cell transcriptomic profiles of rhinophyma and hypertrophic scar tissues to identify key cell types and molecular pathways that may account for the distinct healing fate of rhinophyma post-surgery and provide novel insights for the prevention and treatment of hypertrophic scars. Methods and results: We isolated single cells from rhinophyma and hypertrophic scar tissues and conducted transcriptomic analysis using high-throughput single-cell RNA sequencing technology. Employing bioinformatics methods, we analyzed the data to identify differentially expressed genes and cellular subpopulations. Our results indicate that epithelial cells in hypertrophic scar tissues exhibit distinct fibrotic characteristics not observed in rhinophyma tissues. Vascular structures in hypertrophic scar tissues are enveloped by a significant number of stromal cells, in contrast to the leaky vascular profiles observed in rhinophyma tissues. Furthermore, keratinocytes in hypertrophic scars display disordered proliferation, while the number of immune cells in rhinophyma is significantly higher than in hypertrophic scar tissues. Conclusion: These findings reveal fundamental differences in cellular composition and functionality between rhinophyma and hypertrophic scar tissues, the intrinsic differences in the tissue microenvironment predispose them to divergent healing trajectories following the same insult, offering new perspectives on the healing process of rhinophyma post-surgery and potentially providing molecular targets for the development of scar prevention strategies.